Session Information
-
WCLC 2018
19th World Conference on Lung Cancer
Conference Program for the 19th World Conference on Lung Cancer in Toronto, Canada
Download PDF of the Abstract Book: Click Here.
Presentation Date(s):- Sept 23 - 26, 2018
- Total Presentations: 2391
September 23 Sun
Sep 23 Monday
September 24 Mon
Sep 24 Tuesday
September 25 Tue
Sep 25 Wednesday
September 26 Wed
Sep 26
-
+
P2.01 - Advanced NSCLC (Not CME Accredited Session)
- 16:45 - 18:00
- 9/25/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P2.01-108 - Temporal Heterogeneity of Resistant Mutations in Sequential ALK TKI Treated Lung Cancer Revealed by NGS-Based Liquid Biopsy
16:45 - 18:00 | Presenter: Yu Yang | Author(s): Yan Ding, Xue Wu, Yang W. Shao
- Abstract
Loading... -
+
P2.01-52 - Identification of Leptomeningeal Metastasis-Specific Exosomal miRNA Signatures in Cerebrospinal Fluids of NSCLC Patients
16:45 - 18:00 | Presenter: Yang W. Shao | Author(s): Ben-Yuan Jiang, Yang-Si Li, Xue Wu, Bao Hua, Yan Ding, Jin -Ji Yang, Xu-Chao Zhang, Xue-Ning Yang, Wen-Zhao Zhong, Qing Zhou, Hai-Yan Tu, Cun Yi Gao, Shuyu Wu, Yi-Long Wu
- Abstract
Loading...
-
+
P2.03 - Biology (Not CME Accredited Session)
- 16:45 - 18:00
- 9/25/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P2.03-12 - EGFR and ERBB2 Germline Mutations in Chinese Lung Cancer Patients and Their Roles in Genetic Susceptibility to Cancer
16:45 - 18:00 | Presenter: Shun Lu | Author(s): Yongfeng Yu, Ziming Li, Yang W. Shao, Xue Wu, Yan Ding, Hairong Bao, Hong Jian
- Abstract
Loading...
-
+
P2.13 - Targeted Therapy (Not CME Accredited Session)
- 16:45 - 18:00
- 9/25/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P2.13-07 - CUX1-ALK: A Novel ALK Rearrangement That Responds to Crizotinib in Non-Small-Cell Lung Cancer
16:45 - 18:00 | Presenter: Kaihua Lu | Author(s): Meiling Zhang, Qian Wang, Yan Ding, Guoqun Wang, Yunqian Chu, Xiang He, Xue Wu, Yang W. Shao
- Abstract
Loading...
-
+
MA26 - New Therapies and Emerging Data in ALK, EGFR and ROS1
- 13:30 - 15:00
- 9/26/2018
- Location: Room 201 BD
- Type: Mini Oral Abstract Session
- Track: Targeted Therapy
-
+
MA26.01 - Accumulation of Concomitant Mutations Involved in Drug Resistance in the Sequential ALK TKI Treatments of ALK-Positive NSCLC
13:30 - 13:35 | Presenter: Shun Lu | Author(s): Yongfeng Yu, Yan Ding, Xue Wu, Hairong Bao, Yang W. Shao
- Abstract
Loading...
